Wells Fargo & Company Shattuck Labs, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 14,061 shares of STTK stock, worth $17,295. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,061

Previous 335 4097.31%

Holding current value

$17,295

Previous $2,000 2600.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$3.56 - $11.18 $48,864 - $153,456	13,726 Added 4097.31%	14,061 $54,000
Q1 2024 May 10, 2024	BUY	$7.37 - $10.09 $420 - $575	57 Added 20.5%	335 $2,000
Q4 2023 Feb 09, 2024	BUY	$1.37 - $7.24 $20 - $108	15 Added 5.7%	278 $1,000
Q3 2023 Nov 13, 2023	SELL	$1.42 - $3.16 $15,455 - $34,393	-10,884 Reduced 97.64%	263 $0
Q2 2023 Aug 15, 2023	BUY	$2.52 - $3.66 $27 - $40	11 Added 0.1%	11,147 $34,000
Q1 2023 May 12, 2023	BUY	$2.5 - $4.72 $7 - $14	3 Added 0.03%	11,136 $32,000
Q4 2022 Feb 13, 2023	BUY	$1.96 - $3.26 $13 - $22	7 Added 0.06%	11,133 $25,000
Q3 2022 Nov 14, 2022	BUY	$2.6 - $5.52 $119 - $253	46 Added 0.42%	11,126 $30,000
Q2 2022 Aug 12, 2022	SELL	$2.7 - $4.59 $4,814 - $8,183	-1,783 Reduced 13.86%	11,080 $45,000
Q1 2022 May 16, 2022	SELL	$4.22 - $8.89 $39,874 - $84,001	-9,449 Reduced 42.35%	12,863 $55,000
Q4 2021 Feb 14, 2022	SELL	$8.36 - $21.08 $53,336 - $134,490	-6,380 Reduced 22.24%	22,312 $189,000
Q3 2021 Nov 15, 2021	BUY	$17.57 - $28.95 $500,973 - $825,451	28,513 Added 15929.05%	28,692 $584,000
Q2 2021 Aug 16, 2021	SELL	$24.14 - $37.68 $55,353 - $86,400	-2,293 Reduced 92.76%	179 $5,000
Q1 2021 May 13, 2021	SELL	$27.92 - $52.5 $120,893 - $227,325	-4,330 Reduced 63.66%	2,472 $73,000
Q4 2020 Feb 09, 2021	BUY	$19.0 - $57.61 $129,238 - $391,863	6,802 New	6,802 $356,000

Others Institutions Holding STTK

# of Institutions

Shares Held

26.9M

Call Options Held

3.1K

Put Options Held

23.9K

View Full List

About Shattuck Labs, Inc.

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $52.1M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

More about STTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Shattuck Labs, Inc. Transaction History